Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options

被引：37
|
作者：
Uhlving, H. H. [1 ,2 ]
Buchvald, F. [1 ,3 ]
Heilmann, C. J. [1 ]
Nielsen, K. G. [1 ,3 ]
Gormsen, M. [4 ]
Muller, K. G. [1 ,2 ]
机构：
[1] Rigshosp, Natl Univ Hosp, Paediat Clin, DK-2100 Copenhagen OE, Denmark
[2] Rigshosp, Natl Univ Hosp, Dept Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen OE, Denmark
[3] Rigshosp, Natl Univ Hosp, Paediat Pulm Serv, DK-2100 Copenhagen OE, Denmark
[4] Rigshosp, Natl Univ Hosp, Dept Radiol, DK-2100 Copenhagen OE, Denmark
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷 / 08期
关键词：
bronchiolitis obliterans; allogeneic haematopoietic SCT; chronic graft-versus-host disease; treatment outcome; methylprednisolone; VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; NONINFECTIOUS PULMONARY COMPLICATIONS; CONSENSUS DEVELOPMENT PROJECT; OBSTRUCTIVE LUNG-DISEASE; IDIOPATHIC PNEUMONIA SYNDROME; RECEPTOR FUSION PROTEIN; AIR-FLOW OBSTRUCTION; EXTRACORPOREAL PHOTOPHERESIS;
D O I：
10.1038/bmt.2011.161
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
Bronchiolitis obliterans (BO) following allogeneic haematopoietic SCT (HSCT) is a serious complication affecting 1.7-26% of the patients, with a reported mortality rate of 21-100%. It is considered a manifestation of chronic graft-versus-host disease, but our knowledge of aetiology and pathogenesis is still limited. Diagnostic criteria are being developed, and will allow more uniform and comparable research activities between centres. At present, no randomised controlled trials have been completed that could demonstrate an effective treatment. Steroids in combination with other immunosuppressive drugs still constitute the backbone of the treatment strategy, and results from our and other centres suggest that monthly infusions of high-dose pulse i.v. methylprednisolone (HDPM) might stabilise the disease and hinder progression. This article provides an overview of the current evidence regarding treatment options for BO and presents the treatment results with HDPM in a paediatric national HSCT-cohort. Bone Marrow Transplantation (2012) 47, 1020-1029; doi:10.1038/bmt.2011.161; published online 29 August 2011
引用
收藏
页码：1020 / 1029
页数：10
相关论文
共 50 条
  • [31] Correlation between paraproteinaemia and viral reactivation after allo-SCT
    Metafuni, E.
    Giammarco, S.
    Bellesi, S.
    Chiusolo, P.
    Laurenti, L.
    Sora, F.
    Cattani, P.
    Santangelo, R.
    Manzara, S.
    Leone, G.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 (09) : 1262 - 1262
  • [32] Successful management of Candida krusei monoarthritis after allo-SCT
    K Mayer
    M Kapelle
    A Kaeferstein
    M Weßling
    I Bekeredjian-Ding
    C Leutner
    M von Lilienfeld-Toal
    P Brossart
    D Wolf
    Bone Marrow Transplantation, 2013, 48 : 1585 - 1586
  • [33] Clinical application of MSC-FFM in pediatric patients after Allo-SCT - A case series
    Elgaz, Suemeyye
    Jarisch, Andrea
    Jan, Soerensen
    Rettinger, Eva
    Willasch, Andre Manfred
    Kuci, Selim
    Kuci, Zyrafete
    Boenig, Halvard
    Hutter, Martin
    Bader, Peter
    BONE MARROW TRANSPLANTATION, 2019, 54 : 605 - 606
  • [34] Management of relapse after allo-SCT for AML and the role of second transplantation
    B N Savani
    S Mielke
    N Reddy
    S Goodman
    M Jagasia
    K Rezvani
    Bone Marrow Transplantation, 2009, 44 : 769 - 777
  • [35] Response to 'Correlation between paraproteinaemia and viral reactivation after allo-SCT'
    Medd, P. G.
    Peniket, A. J.
    Littlewood, T. J.
    BONE MARROW TRANSPLANTATION, 2012, 47 (09) : 1263 - 1263
  • [36] Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
    L De Padua Silva
    M de Lima
    H Kantarjian
    S Faderl
    P Kebriaei
    S Giralt
    J Davisson
    G Garcia-Manero
    R Champlin
    J-P Issa
    F Ravandi
    Bone Marrow Transplantation, 2009, 43 : 839 - 843
  • [37] Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
    Silva, L. De Padua
    de Lima, M.
    Kantarjian, H.
    Faderl, S.
    Kebriaei, P.
    Giralt, S.
    Davisson, J.
    Garcia-Manero, G.
    Champlin, R.
    Issa, J-P
    Ravandi, F.
    BONE MARROW TRANSPLANTATION, 2009, 43 (11) : 839 - 843
  • [38] Response to ‘Correlation between paraproteinaemia and viral reactivation after allo-SCT’
    P G Medd
    A J Peniket
    T J Littlewood
    Bone Marrow Transplantation, 2012, 47 : 1263 - 1263
  • [39] Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT
    M Tobiasson
    R Olsson
    E Hellström-Lindberg
    J Mattsson
    Bone Marrow Transplantation, 2011, 46 : 719 - 726
  • [40] Early detection of relapse in patients with myelodysplastic syndrome after allo-SCT
    Tobiasson, M.
    Olsson, R.
    Hellstrom-Lindberg, E.
    Mattsson, J.
    BONE MARROW TRANSPLANTATION, 2011, 46 (05) : 719 - 726
12345